i3 Health

https://i3health.com/

 

i3 Health
A

ODACon™ Supportive Care Summit: Managing Toxicities of Novel Breast Cancer Therapies - Monoclonal Antibodies

By i3 Health FEATURING Abbey Kaler
By i3 Health FEATURING Abbey Kaler
16 views
December 30, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy
ODACon
08:35

ODACon™ Supportive Care Summit: Managing Toxicities of Novel Breast …

i3 Health

J. Metsker

27 views
07:59

ODACon™ Supportive Care Summit: Managing Toxicities of Novel Breast …

i3 Health

J. Metsker

17 views
06:47

ODACon™ Supportive Care Summit: Managing Toxicities of Novel Breast …

i3 Health

A. Kaler

16 views
07:57

ODACon™ Supportive Care Summit: Managing Toxicities of Novel Breast …

i3 Health

J. Labarbera

18 views
07:25

ODACon™ Supportive Care Summit: Managing Toxicities of Novel Breast …

i3 Health

C. Visovsky

12 views
07:41

ODACon™ Supportive Care Summit: Managing Toxicities of Novel Breast …

i3 Health

J. Labarbera

30 views